Skip to content

4Accepted Sep 17, 4:17 PM ET

Medtronic (MDT) EVP Harry Skip Kiil Sells 1,483 Shares

MDTMedtronic plc

Accepted (ET)

4:17 PM

Sep 17, 2026

Filed

Sep 17, 2026

Documents

1

Size

5.0 KB

Summary

Medtronic (MDT) EVP Harry Skip Kiil Sells 1,483 Shares

Updated

What Happened Harry Skip Kiil, EVP & President, Cardiovascular at Medtronic plc (MDT), reported a sale of 1,483 shares on 2026-09-16. The shares were disposed at $93.65 each, for a gross transaction value of approximately $138,883. This was a sale (transaction code S); sales are common insider activity and do not by themselves indicate a change in company prospects.

Key Details

  • Transaction date and price: 2026-09-16 at $93.65 per share.
  • Shares sold: 1,483; gross proceeds ≈ $138,883.
  • Transaction type: Reported as an open-market or private sale (Form 4 lists "open market or private sale").
  • Shares owned after transaction: Not provided in the data supplied.
  • Filing: Form 4 filed 2026-09-17 (appears timely; no late‑filing flag noted).
  • No footnotes, 10b5-1 plan, option exercise, gift, or tax‑withholding details were included in the provided information.

Context

  • This transaction was a straightforward sale (S). Unlike purchases, insider sales are often routine (e.g., portfolio rebalancing or liquidity needs) and should not be interpreted alone as a signal about company fundamentals.
  • Retail investors should consider this alongside other insider filers, company disclosures, and broader market/company fundamentals before drawing conclusions.

AI-written summary · check the filing